Gene Editing Market

1.Executive Summary

2.Introduction
   2.1.Study Objectives
   2.2.Market Definition
         2.2.1. Market Covered
         2.2.2.Geographical Coverage
         2.2.3.Study Years & Currency
   2.3.Market Stakeholders
   2.4.Key Questions this Study will Answer
   2.5.GMI Research’s Approach & Methodology

3.Global Gene Editing Market - Overview
   3.1.Introduction
   3.2.Market Segmentation
   3.3. Value Chain Analysis
   3.4.Drivers
   3.5.Restraints
   3.6.Trends

4.Global Gene Editing Market Revenue Forecast till 2029

5.Global Gene Editing Market by Technology Revenue Forecast till 2029
   5.1.Cluster Regularly Interspaced Short Palindromic Repeats (CRISPR)
   5.2.Transcription Activator-Like Effector Nucleases (TALEN)
   5.3.Zing Finger Nucleases (ZFN)
   5.4.Others

6.Global Gene Editing Market by Application Revenue Forecast till 2029
   6.1.Animal Genetic Engineering
         6.1.1.Therapeutic Application
         6.1.2.Genetically Modified Organisms
   6.2.Plant Genetic Engineering
   6.3.Cell Line Engineering

7.Global Gene Editing Market by End User Revenue Forecast till 2029
   7.1.Pharma-BioTech Companies
   7.2.Academic Institutes & Research Center
   7.3.Agrigenomic Companies
   7.4.Contract Research Organization

8.Global Gene Editing Market by Geography Revenue Forecast till 2029
   8.1.North America Global Gene Editing Market Revenue Forecast till 2029
         8.1.1. North America Global Gene Editing Market by Technology (Option 1: 25% customization)
                   8.1.1.1.Cluster Regularly Interspaced Short Palindromic Repeats (CRISPR)
                   8.1.1.2.Transcription Activator-Like Effector Nucleases (TALEN)
                   8.1.1.3.Zing Finger Nucleases (ZFN)
                   8.1.1.4.Others

         8.1.2. North America Global Gene Editing Market by Application
                   8.1.2.1.Animal Genetic Engineering
                               8.1.2.1.1.Therapeutic Application
                               8.1.2.1.2.Genetically Modified Organisms
                   8.1.2.2.Plant Genetic Engineering
                   8.1.2.3.Cell Line Engineering

         8.1.3. North America Global Gene Editing Market by End User
                   8.1.3.1.Pharma-BioTech Companies
                   8.1.3.2.Academic Institutes & Research Center
                   8.1.3.3.Agrigenomic Companies
                   8.1.3.4.Contract Research Organization

   8.2.Europe Global Gene Editing Market Revenue Forecast till 2029
         8.2.1. Europe Global Gene Editing Market by Technology (Option 1: 25% customization)
                   8.2.1.1.Cluster Regularly Interspaced Short Palindromic Repeats (CRISPR)
                   8.2.1.2.Transcription Activator-Like Effector Nucleases (TALEN)
                   8.2.1.3.Zing Finger Nucleases (ZFN)
                   8.2.1.4.Others

         8.2.2. Europe Global Gene Editing Market by Application
                   8.2.2.1.Animal Genetic Engineering
                               8.2.2.1.1.Therapeutic Application
                               8.2.2.1.2.Genetically Modified Organisms
                   8.2.2.2.Plant Genetic Engineering
                   8.2.2.3.Cell Line Engineering

         8.2.3. Europe Global Gene Editing Market by End User
                   8.2.3.1.Pharma-BioTech Companies
                   8.2.3.2.Academic Institutes & Research Center
                   8.2.3.3.Agrigenomic Companies
                   8.2.3.4.Contract Research Organization

   8.3.Asia-Pacific Global Gene Editing Market Revenue Forecast till 2029
         8.3.1. Asia-Pacific Global Gene Editing Market by Technology (Option 1: 25% customization)
                   8.3.1.1.Cluster Regularly Interspaced Short Palindromic Repeats (CRISPR)
                   8.3.1.2.Transcription Activator-Like Effector Nucleases (TALEN)
                   8.3.1.3.Zing Finger Nucleases (ZFN)
                   8.3.1.4.Others

         8.3.2. Asia-Pacific Global Gene Editing Market by Application
                   8.3.2.1.Animal Genetic Engineering
                               8.3.2.1.1.Therapeutic Application
                               8.3.2.1.2.Genetically Modified Organisms
                   8.3.2.2.Plant Genetic Engineering
                   8.3.2.3.Cell Line Engineering

         8.3.3. Asia-Pacific Global Gene Editing Market by End User
                   8.3.3.1.Pharma-BioTech Companies
                   8.3.3.2.Academic Institutes & Research Center
                   8.3.3.3.Agrigenomic Companies
                   8.3.3.4.Contract Research Organization

   8.4.Rest of the World Global Gene Editing Market Revenue Forecast till 2029
         8.4.1. Rest of the World Global Gene Editing Market by Technology (Option 1: 25% customization)
                   8.4.1.1.Cluster Regularly Interspaced Short Palindromic Repeats (CRISPR)
                   8.4.1.2.Transcription Activator-Like Effector Nucleases (TALEN)
                   8.4.1.3.Zing Finger Nucleases (ZFN)
                   8.4.1.4.Others

         8.4.2. Rest of the World Global Gene Editing Market by Application
                   8.4.2.1.Animal Genetic Engineering
                               8.4.2.1.1.Therapeutic Application
                               8.4.2.1.2.Genetically Modified Organisms
                   8.4.2.2.Plant Genetic Engineering
                   8.4.2.3.Cell Line Engineering

         8.4.3. Rest of the World Global Gene Editing Market by End User
                   8.4.3.1.Pharma-BioTech Companies
                   8.4.3.2.Academic Institutes & Research Center
                   8.4.3.3.Agrigenomic Companies
                   8.4.3.4.Contract Research Organization

9.Competitive Landscape
   9.1.Porter 5 Analysis
   9.2.Major players and their key strategies
   9.3.Company Share Analysis

10.Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
     10.1. CRISPR Therapeutics
              10.1.1.Company Overview
              10.1.2.Financials
              10.1.3.Recent Developments

     10.2. Sangamo Therapeutics
              10.2.1.Company Overview
              10.2.2.Financials
              10.2.3.Recent Developments

     10.3. Editas Medicine
              10.3.1.Company Overview
              10.3.2.Financials
              10.3.3.Recent Developments

     10.4. Intellia Therapeutic
              10.4.1.Company Overview
              10.4.2.Financials
              10.4.3.Recent Developments

     10.5.Cellectics
              10.5.1.Company Overview
              10.5.2.Financials
              10.5.3.Recent Developments

     10.6. Agilent Technologies
              10.6.1.Company Overview
              10.6.2.Financials
              10.6.3.Recent Developments

     10.7. Allele Biotech
              10.7.1.Company Overview
              10.7.2.Financials
              10.7.3.Recent Developments

     10.8.Bio Rad
              10.8.1.Company Overview
              10.8.2.Financials
              10.8.3.Recent Developments

     10.9. Thermo Fischer Scientific
              10.9.1.Company Overview
              10.9.2.Financials
              10.9.3.Recent Developments

     10.10.DNA Technologies
              10.10.1.Company Overview
              10.10.2.Financials
              10.10.3.Recent Developments

11.About GMI Research